ID   NALM-12
AC   CVCL_5660
SY   NALM12; Nalm 12
DR   Wikidata; Q54907394
RX   CelloPub=CLPUB00085;
RX   PubMed=2939141;
CC   Population: Caucasian.
CC   HLA typing: A*01,02; B*15 (PubMed=2939141).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW76 ! B85
OI   CVCL_0092 ! NALM-6
OI   CVCL_5677 ! NALM-7
OI   CVCL_L057 ! NALM-8
OI   CVCL_L058 ! NALM-9
OI   CVCL_L059 ! NALM-10
OI   CVCL_L060 ! NALM-11
OI   CVCL_L061 ! NALM-13
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
RX   CelloPub=CLPUB00085;
RA   Minowada J., Oshimura M., Abe S., Greaves M.F., Janossy G.,
RA   Sandberg A.A.;
RT   "Human leukemia cell lines. Evidence for differentiation toward T- and
RT   B-cell axis within a leukemia clone.";
RL   Proc. Am. Assoc. Cancer Res. 19:109-109(1978).
//
RX   PubMed=2939141; DOI=10.4049/jimmunol.136.11.4311;
RA   Pesando J.M., Graf L.;
RT   "Differential expression of HLA-DR, -DQ, and -DP antigens on malignant
RT   B cells.";
RL   J. Immunol. 136:4311-4318(1986).
//